Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-1010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-1010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of Atorvastatin Calcium depicted with detailed molecular groups, including multiple phenyl rings, hydroxyl groups, and calcium ion with three water molecules. The structure is shown in a bracketed formula indicating two calcium ions complexed with the molecule.*
FDA Label Image

Figure1 (Image 02)

Figure1 (Image 02)
A line graph showing cumulative incidence percentage over time in years, comparing Atorvastatin with Placebo. The solid line represents Atorvastatin, and the dashed line represents Placebo, with Atorvastatin showing a lower cumulative incidence rate throughout the 3.5-year period.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A line graph depicting cumulative hazard percentage over time in years, comparing Atorvastatin versus placebo over a four-year follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard (%). Atorvastatin's curve remains below placebo, indicating a lower cumulative hazard, with a hazard ratio (HR) of 0.63 (0.48-0.83), p=0.001.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A line graph comparing two doses of Atorvastatin (10 mg and 80 mg) showing the percentage of subjects experiencing the first major cardiovascular event over five years. The graph plots time in years on the x-axis against the percentage of subjects experiencing the event on the y-axis. The 80 mg dose line shows a lower event rate compared to the 10 mg dose, with a hazard ratio of 0.78 (95% CI 0.69-0.89) and a P-value of 0.0002.*
FDA Label Image

Label Image (Lbl713351010)

Label Image (Lbl713351010)
Atorvastatin Calcium Tablets, USP 20 mg film-coated oral tablets by Bryant Ranch Prepack. The label shows the product NDC 71335-1010, with a package size of 30 tablets, indicated as Rx only. Storage instructions and repackager information (Bryant Ranch Prepack, Inc., Burbank, CA) are also displayed alongside a barcode and a highlighted dosage strength box.*
FDA Label Image

Lbl7133510102

Lbl7133510102
Label for Atorvastatin Calcium 20 mg film-coated tablets, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates comparison to Lipitor 20 mg tablets by Sun Pharma Industries Ltd. The package contains 30 tablets with an NDC of 71335-1010-1. Storage instructions specify room temperature between 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.